Novavax Total Assets 2006-2021 | NVAX

Novavax total assets from 2006 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Novavax total assets for the quarter ending March 31, 2021 were $2.608B, a 695.07% increase year-over-year.
  • Novavax total assets for 2020 were $1.582B, a 814.96% increase from 2019.
  • Novavax total assets for 2019 were $0.173B, a 16.84% decline from 2018.
  • Novavax total assets for 2018 were $0.208B, a 31.25% decline from 2017.
Novavax Annual Total Assets
(Millions of US $)
2020 $1,582
2019 $173
2018 $208
2017 $302
2016 $394
2015 $386
2014 $276
2013 $235
2012 $102
2011 $67
2010 $75
2009 $86
2008 $77
2007 $91
2006 $122
2005 $84
Novavax Quarterly Total Assets
(Millions of US $)
2021-03-31 $2,608
2020-12-31 $1,582
2020-09-30 $944
2020-06-30 $932
2020-03-31 $328
2019-12-31 $173
2019-09-30 $165
2019-06-30 $189
2019-03-31 $221
2018-12-31 $208
2018-09-30 $250
2018-06-30 $286
2018-03-31 $276
2017-12-31 $302
2017-09-30 $334
2017-06-30 $356
2017-03-31 $362
2016-12-31 $394
2016-09-30 $460
2016-06-30 $525
2016-03-31 $593
2015-12-31 $386
2015-09-30 $405
2015-06-30 $425
2015-03-31 $439
2014-12-31 $276
2014-09-30 $293
2014-06-30 $312
2014-03-31 $219
2013-12-31 $235
2013-09-30 $245
2013-06-30 $93
2013-03-31 $99
2012-12-31 $102
2012-09-30 $81
2012-06-30 $77
2012-03-31 $69
2011-12-31 $67
2011-09-30 $67
2011-06-30 $69
2011-03-31 $70
2010-12-31 $75
2010-09-30 $79
2010-06-30 $69
2010-03-31 $75
2009-12-31 $86
2009-09-30 $76
2009-06-30 $73
2009-03-31 $68
2008-12-31 $77
2008-09-30 $90
2008-06-30 $81
2008-03-31 $86
2007-12-31 $91
2007-09-30 $100
2007-06-30 $108
2007-03-31 $115
2006-12-31 $122
2006-09-30 $125
2006-06-30 $131
2006-03-31 $135
2005-12-31 $84
2005-09-30 $61
2005-06-30 $60
2005-03-31 $67
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $13.329B $0.476B
NOVAVAX INC is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on women's health and infectious diseases. Their technology platforms involve the use of proprietary, microscopic, organized, non-phospholipid structures as vehicles for the delivery of a wide variety of drugs and other therapeutic products, including certain hormones, anti-bacterial and anti-viral products and vaccine adjuvants.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $149.087B 10.34
Amgen (AMGN) United States $138.330B 14.93
CSL (CSLLY) Australia $104.641B 0.00
Gilead Sciences (GILD) United States $84.306B 8.97
Moderna (MRNA) United States $81.297B 161.98
Illumina (ILMN) United States $66.481B 95.86
Biogen (BIIB) United States $57.741B 13.22
Regeneron Pharmaceuticals (REGN) United States $57.109B 16.35
BioNTech SE (BNTX) Germany $51.734B 37.51
Vertex Pharmaceuticals (VRTX) United States $48.760B 20.08
Alexion Pharmaceuticals (ALXN) United States $39.777B 15.11
BeiGene (BGNE) Cayman Islands $30.286B 0.00
Genmab (GMAB) Denmark $28.565B 33.49
Seagen (SGEN) United States $27.835B 48.08
Genmab (GNMSF) Denmark $27.247B 6.27
Exact Sciences (EXAS) United States $21.770B 0.00
Horizon Therapeutics Public (HZNP) Ireland $20.710B 26.48
Alnylam Pharmaceuticals (ALNY) United States $20.247B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Incyte (INCY) United States $18.282B 36.14
Bio-Techne Corp (TECH) United States $17.314B 91.04
Bio-Rad Laboratories (BIO.B) United States $17.251B 41.91
ARGENX SE-ADR (ARGX) Netherlands $16.157B 0.00
Zai Lab (ZLAB) China $15.289B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.164B 138.30
Guardant Health (GH) United States $12.508B 0.00
Repligen (RGEN) United States $10.961B 98.83
CureVac (CVAC) Germany $10.809B 0.00
QIAGEN (QGEN) Netherlands $10.663B 18.93
CRISPR Therapeutics AG (CRSP) Switzerland $9.643B 0.00
Denali Therapeutics (DNLI) United States $9.066B 325.26
Mirati Therapeutics (MRTX) United States $8.573B 0.00
Fate Therapeutics (FATE) United States $7.919B 0.00
Acceleron Pharma (XLRN) United States $7.728B 0.00
Ascendis Pharma (ASND) Denmark $7.428B 0.00
Exelixis (EXEL) United States $6.935B 110.65
Ultragenyx Pharmaceutical (RARE) United States $6.477B 0.00
Sarepta Therapeutics (SRPT) United States $6.389B 0.00
AbCellera Biologics (ABCL) $6.180B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $6.135B 0.00
Halozyme Therapeutics (HALO) United States $6.114B 33.55
Vir Biotechnology (VIR) United States $5.698B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.628B 20.39
Adaptive Biotechnologies (ADPT) United States $5.587B 0.00
Twist Bioscience (TWST) United States $5.547B 0.00
I-Mab (IMAB) China $5.407B 0.00
Beam Therapeutics (BEAM) United States $5.319B 0.00
Intellia Therapeutics (NTLA) United States $5.214B 0.00
Legend Biotech (LEGN) United States $5.155B 0.00
NeoGenomics (NEO) United States $5.139B 871.60
Reata Pharmaceuticals (RETA) United States $5.073B 0.00
Galapagos (GLPG) Belgium $4.984B 0.00
Blueprint Medicines (BPMC) United States $4.873B 14.84
Apellis Pharmaceuticals (APLS) United States $4.814B 0.00
Certara (CERT) United States $4.212B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.141B 0.00
Arena Pharmaceuticals (ARNA) United States $4.030B 0.00
Alkermes (ALKS) Ireland $3.962B 0.00
SpringWorks Therapeutics (SWTX) United States $3.893B 0.00
Arvinas (ARVN) United States $3.853B 0.00
Intra-Cellular Therapies (ITCI) United States $3.505B 0.00
Emergent Biosolutions (EBS) United States $3.382B 6.74
Berkeley Lights (BLI) United States $3.296B 0.00
Insmed (INSM) United States $3.025B 0.00
Vericel (VCEL) United States $2.827B 762.25
BAVARIAN NORDIC (BVNRY) Denmark $2.811B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.751B 0.00
Amicus Therapeutics (FOLD) United States $2.714B 0.00
MorphoSys AG (MOR) Germany $2.630B 0.00
Sorrento Therapeutics (SRNE) United States $2.492B 0.00
Editas Medicine (EDIT) United States $2.453B 0.00
ALX Oncology Holdings (ALXO) United States $2.426B 0.00
Heska (HSKA) United States $2.395B 1044.14
Myriad Genetics (MYGN) United States $2.363B 0.00
Morphic Holding (MORF) United States $2.342B 0.00
Instil Bio (TIL) United States $2.325B 0.00
Global Blood Therapeutics (GBT) United States $2.309B 0.00
Bluebird Bio (BLUE) United States $2.224B 0.00
Revance Therapeutics (RVNC) United States $2.197B 0.00
Bionano Genomics (BNGO) United States $2.192B 0.00
Prothena (PRTA) Ireland $2.152B 0.00
Kymera Therapeutics (KYMR) United States $2.146B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.135B 0.00
Ligand Pharmaceuticals (LGND) United States $2.128B 35.60
Seer (SEER) $2.069B 0.00
Amarin (AMRN) Ireland $1.946B 0.00
Seres Therapeutics (MCRB) United States $1.916B 0.00
Castle Biosciences (CSTL) United States $1.907B 0.00
Myovant Sciences (MYOV) United Kingdom $1.896B 0.00
Protagonist Therapeutics (PTGX) United States $1.896B 0.00
Atea Pharmaceuticals (AVIR) United States $1.891B 0.00
Inovio Pharmaceuticals (INO) United States $1.847B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.817B 0.00
PHARMA MAR SA (PHMMF) Spain $1.777B 0.00
Genetron Holdings (GTH) China $1.767B 0.00
Zymeworks (ZYME) Canada $1.763B 0.00
Alector (ALEC) United States $1.705B 0.00
Arcus Biosciences (RCUS) United States $1.688B 0.00
Sangamo Therapeutics (SGMO) United States $1.647B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.640B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.626B 0.00
REGENXBIO (RGNX) United States $1.611B 0.00
C4 Therapeutics (CCCC) United States $1.602B 0.00
UniQure (QURE) Netherlands $1.588B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.585B 0.00
Cytokinetics (CYTK) United States $1.574B 0.00
NGM Biopharmaceuticals (NGM) United States $1.531B 0.00
PureTech Health (PRTC) United States $1.462B 0.00
Avid Bioservices (CDMO) United States $1.442B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.372B 0.00
Zealand Pharma (ZEAL) Denmark $1.348B 0.00
MiMedx (MDXG) United States $1.342B 0.00
Nurix Therapeutics (NRIX) United States $1.316B 0.00
Northwest Biotherapeutics (NWBO) United States $1.316B 0.00
Precigen (PGEN) United States $1.313B 0.00
Ocugen (OCGN) United States $1.296B 0.00
BioAtla (BCAB) United States $1.292B 0.00
Codexis (CDXS) United States $1.267B 0.00
Repare Therapeutics (RPTX) Canada $1.255B 0.00
Shattuck Labs (STTK) United States $1.245B 0.00
Keros Therapeutics (KROS) United States $1.224B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.201B 0.00
Agenus (AGEN) United States $1.183B 0.00
Zealand Pharma (ZLDPF) Denmark $1.135B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.123B 0.00
Celldex Therapeutics (CLDX) United States $1.109B 0.00
MannKind (MNKD) United States $1.106B 0.00
Pliant Therapeutics (PLRX) United States $1.096B 0.00
Coherus BioSciences (CHRS) United States $1.089B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.086B 34.30
Mesoblast (MESO) Australia $1.081B 0.00
Scholar Rock Holding (SRRK) United States $1.061B 0.00
Dynavax Technologies (DVAX) United States $1.036B 0.00
Prometheus Biosciences (RXDX) United States $1.034B 0.00
Avidity Biosciences (RNA) United States $1.008B 0.00
VBI Vaccines (VBIV) United States $1.004B 0.00
Mersana Therapeutics (MRSN) United States $0.998B 0.00
Inhibrx (INBX) United States $0.979B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.944B 0.00
Travere Therapeutics (TVTX) United States $0.929B 0.00
G1 THERAPEUTICS (GTHX) United States $0.924B 0.00
Epizyme (EPZM) United States $0.898B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.892B 0.00
Cel-Sci (CVM) United States $0.885B 0.00
Sutro Biopharma (STRO) United States $0.864B 0.00
RAPT THERAPTICS (RAPT) United States $0.835B 0.00
Nkarta (NKTX) United States $0.832B 0.00
Verastem (VSTM) United States $0.820B 0.00
Merus (MRUS) Netherlands $0.805B 0.00
Affimed (AFMD) Germany $0.792B 0.00
SESEN BIO, INC (SESN) United States $0.780B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 20.00
IDEAYA Biosciences (IDYA) United States $0.748B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.744B 0.00
Pharming Group (PHAR) Netherlands $0.740B 0.00
Cara Therapeutics (CARA) United States $0.733B 63.70
Kadmon Holdings (KDMN) United States $0.719B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.715B 0.00
Curis (CRIS) United States $0.698B 0.00
Clene (CLNN) United States $0.690B 0.00
Cellectis S.A (CLLS) France $0.687B 0.00
DBV Technologies S.A (DBVT) France $0.687B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.684B 0.00
AnaptysBio (ANAB) United States $0.683B 0.00
ChromaDex (CDXC) United States $0.679B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.671B 0.00
MeiraGTx Holdings (MGTX) United States $0.665B 0.00
ALBIREO PHARMA (ALBO) United States $0.655B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.655B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.650B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Clovis Oncology (CLVS) United States $0.637B 0.00
Precision BioSciences (DTIL) United States $0.613B 0.00
Adagene (ADAG) China $0.609B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.599B 0.00
Anika Therapeutics (ANIK) United States $0.591B 0.00
Bolt Biotherapeutics (BOLT) United States $0.583B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.582B 0.00
Selecta Biosciences (SELB) United States $0.563B 0.00
Inventiva S.A (IVA) France $0.562B 0.00
Codiak BioSciences (CDAK) United States $0.552B 0.00
AC Immune SA (ACIU) Switzerland $0.541B 0.00
Forte Biosciences (FBRX) United States $0.540B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.537B 0.00
Compugen (CGEN) Israel $0.534B 0.00
Starpharma Holdings (SPHRY) Australia $0.506B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.496B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Gritstone Bio (GRTS) United States $0.487B 0.00
XBiotech (XBIT) United States $0.486B 0.00
CytomX Therapeutics (CTMX) United States $0.466B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.460B 0.00
Athenex (ATNX) United States $0.454B 0.00
Oncobiologics (OTLK) United States $0.451B 0.00
Spero Therapeutics (SPRO) United States $0.450B 0.00
Geron (GERN) United States $0.449B 0.00
BeyondSpring (BYSI) United States $0.443B 0.00
Neoleukin Therapeutics (NLTX) United States $0.434B 0.00
AquaBounty Technologies (AQB) United States $0.423B 0.00
Amryt Pharma (AMYT) United Kingdom $0.421B 0.00
ANI Pharmaceuticals (ANIP) United States $0.417B 11.51
Kindred Biosciences (KIN) United States $0.416B 0.00
Cue Biopharma (CUE) United States $0.412B 0.00
Puma Biotechnology (PBYI) United States $0.412B 0.00
Opthea (OPT) Australia $0.395B 0.00
Angion Biomedica (ANGN) United States $0.395B 0.00
SQZ Biotechnologies (SQZ) United States $0.384B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.382B 0.00
Kala Pharmaceuticals (KALA) United States $0.380B 0.00
Adverum Biotechnologies (ADVM) United States $0.365B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.361B 0.00
WAVE Life Sciences (WVE) Singapore $0.357B 0.00
BioDelivery Sciences (BDSI) United States $0.355B 14.40
UROGEN PHARMA (URGN) United States $0.351B 0.00
Fortress Biotech (FBIO) United States $0.350B 0.00
Cogent Biosciences (COGT) United States $0.349B 0.00
Syros Pharmaceuticals (SYRS) United States $0.348B 0.00
XOMA (XOMA) United States $0.347B 162.16
Frequency Therapeutics (FREQ) United States $0.347B 0.00
Athersys (ATHX) United States $0.344B 0.00
Theratechnologies (THTX) Canada $0.341B 0.00
Prima BioMed (IMMP) Australia $0.339B 0.00
Cerecor (CERC) United States $0.336B 0.00
IBio (IBIO) United States $0.335B 0.00
Adicet Bio (ACET) United States $0.334B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.320B 0.00
Arbutus Biopharma (ABUS) United States $0.314B 0.00
Trevena (TRVN) United States $0.311B 0.00
OVID THERAPEUTC (OVID) United States $0.302B 2.97
CorMedix Inc (CRMD) United States $0.299B 0.00
Cardiff Oncology (CRDF) United States $0.294B 0.00
Innate Pharma S.A (IPHA) France $0.293B 0.00
Kaleido Biosciences (KLDO) $0.287B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
Fulcrum Therapeutics (FULC) United States $0.280B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.276B 0.00
Bellus Health (BLU) Canada $0.268B 0.00
Clearside Biomedical (CLSD) United States $0.267B 0.00
Talis Biomedical (TLIS) United States $0.261B 0.00
INmune Bio (INMB) United States $0.260B 0.00
Kamada (KMDA) Israel $0.257B 17.51
HOOKIPA Pharma (HOOK) United States $0.252B 0.00
Seelos Therapeutics (SEEL) United States $0.248B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.241B 0.00
Chiasma (CHMA) United States $0.239B 0.00
ADMA Biologics Inc (ADMA) United States $0.229B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.228B 0.00
Synlogic (SYBX) United States $0.227B 0.00
NextCure (NXTC) United States $0.226B 0.00
Checkpoint Therapeutics (CKPT) United States $0.223B 0.00
Aptinyx (APTX) United States $0.222B 0.00
TELA Bio (TELA) United States $0.217B 0.00
VTv Therapeutics (VTVT) United States $0.200B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Strongbridge Biopharma (SBBP) United States $0.192B 0.00
X4 Pharmaceuticals (XFOR) United States $0.192B 0.00
Biofrontera AG (BFRA) Germany $0.189B 0.00
Applied Genetic Technologies (AGTC) United States $0.188B 0.00
OSMOTICA PHARM (OSMT) United States $0.184B 0.00
GENFIT S.A (GNFT) France $0.182B 0.00
PHASEBIO PHARMA (PHAS) United States $0.181B 0.00
Voyager Therapeutics (VYGR) United States $0.175B 4.51
VolitionRX (VNRX) United States $0.175B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.174B 0.00
Galena Biopharma (SLS) United States $0.173B 0.00
ObsEva SA (OBSV) Switzerland $0.171B 0.00
Nicox SA (NICXF) France $0.171B 0.00
Abeona Therapeutics (ABEO) United States $0.169B 0.00
Eton Pharmaceuticals (ETON) United States $0.154B 0.00
Antibe Therapeutics (ATBPF) Canada $0.153B 0.00
DiaMedica Therapeutics (DMAC) United States $0.150B 0.00
Cyclerion Therapeutics (CYCN) United States $0.149B 0.00
Exicure (XCUR) United States $0.147B 0.00
Enzo Biochem (ENZ) United States $0.141B 41.43
Eyenovia (EYEN) United States $0.140B 0.00
Liquidia Technologies (LQDA) United States $0.139B 0.00
Catalyst Biosciences (CBIO) United States $0.139B 0.00
Novogen (KZIA) Australia $0.137B 0.00
Longeveron (LGVN) United States $0.135B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.134B 0.00
LogicBio Therapeutics (LOGC) United States $0.132B 0.00
Palatin Technologies (PTN) United States $0.132B 0.00
Erytech Pharma SA (ERYP) France $0.132B 0.00
ABVC BioPharma (ABVC) United States $0.127B 0.00
Cocrystal Pharma (COCP) United States $0.127B 0.00
Aptevo Therapeutics (APVO) United States $0.126B 0.00
Yumanity Therapeutics (YMTX) United States $0.126B 0.00
Aytu BioPharma (AYTU) United States $0.125B 0.00
Liminal BioSciences (LMNL) Canada $0.125B 0.00
Pluristem Therapeutics (PSTI) Israel $0.124B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.124B 0.00
Entera Bio (ENTX) Israel $0.123B 0.00
Evofem Biosciences (EVFM) United States $0.119B 0.00
Orgenesis (ORGS) United States $0.119B 243.50
Beyond Air (XAIR) United States $0.117B 0.00
Vyant Bio (VYNT) United States $0.115B 0.00
Celsion (CLSN) United States $0.114B 0.00
Vascular Biogenics (VBLT) Israel $0.112B 0.00
AEterna Zentaris (AEZS) United States $0.110B 0.00
Zosano Pharma (ZSAN) United States $0.106B 0.00
Armata Pharmaceuticals (ARMP) United States $0.104B 0.00
Leap Therapeutics (LPTX) United States $0.103B 0.00
CytRx (CYTR) United States $0.103B 0.00
TRACON Pharmaceuticals (TCON) United States $0.102B 0.00
ARAVIVE, INC (ARAV) United States $0.101B 0.00
Cidara Therapeutics (CDTX) United States $0.101B 0.00
Evogene (EVGN) Israel $0.097B 0.00
Dyadic (DYAI) United States $0.095B 0.00
Protalix BioTherapeutics (PLX) Israel $0.093B 0.00
AIkido Pharma (AIKI) United States $0.090B 0.00
Lumos Pharma (LUMO) United States $0.090B 0.00
Purple Biotech (PPBT) Israel $0.089B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.089B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.085B 0.00
BioCardia (BCDA) United States $0.081B 0.00
Emmaus Life Sciences (EMMA) United States $0.079B 0.00
Vaccinex (VCNX) United States $0.077B 0.00
Adocia (ADOCY) France $0.077B 0.00
ARIDIS PHARMACT (ARDS) United States $0.076B 0.00
Edesa Biotech (EDSA) Canada $0.076B 0.00
Celyad SA (CYAD) Belgium $0.075B 0.00
Cleveland BioLabs (CBLI) United States $0.075B 0.00
ATyr Pharma (LIFE) United States $0.075B 0.00
Viridian Therapeutics (VRDN) United States $0.072B 0.00
Advaxis (ADXS) United States $0.071B 0.00
Alimera Sciences (ALIM) United States $0.068B 0.00
Cyclo Therapeutics (CYTH) United States $0.067B 0.00
Genetic Technologies (GENE) Australia $0.063B 0.00
Organovo Holdings (ONVO) United States $0.063B 0.00
Idera Pharmaceuticals (IDRA) United States $0.062B 0.00
Pulmatrix (PULM) United States $0.059B 0.00
Windtree Therapeutics (WINT) United States $0.058B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.057B 0.00
AnPac Bio-Medical Science (ANPC) China $0.052B 0.00
Enzon Pharmaceuticals (ENZN) United States $0.052B 0.00
Soligenix (SNGX) United States $0.048B 0.00
Enveric Biosciences (ENVB) United States $0.048B 0.00
Acorda Therapeutics (ACOR) United States $0.046B 1.11
Invo BioScience (INVO) United States $0.046B 0.00
Timber Pharmaceuticals (TMBR) United States $0.043B 0.00
Happiness Biotech Group (HAPP) China $0.041B 0.00
GeoVax Labs (GOVX) United States $0.035B 0.00
Lexaria Bioscience (LEXX) Canada $0.035B 0.00
ThermoGenesis Holdings (THMO) United States $0.034B 0.00
Benitec Biopharma (BNTC) United States $0.033B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.033B 0.00
Vallon Pharmaceuticals (VLON) United States $0.033B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.032B 0.00
Prana Biotechnology (ATHE) Australia $0.032B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.024B 0.00
ZIVO Bioscience (ZIVO) United States $0.024B 0.00
Palisade Bio (PALI) United States $0.012B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00